ETFIQData as of Nov 18, 2026. · etfiq.com/funds/grpz

GRPZ Fact Sheet: Invesco S&P SmallCap 600 GARP ETF

Share
$31.38
close, Nov 18, 2026

Over the year to Nov 18, 2026, GRPZ returned +24.3% in total and charged 0.35% a year.

1-year total return
+24.3%
to Nov 18, 2026
Expense ratio
0.35%
a year
Net assets
$3.1m
on Nov 17, 2026
Net flow, last 5 trading days
$0
daily basis to Nov 17, 2026

Growth of $10,000, 1 year

GRPZ $12,433 +24.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.

Returns

WindowTotal return
1 month+1.6%
3 months−5.7%
Year to date+18.9%
1 year+24.3%
Since launch+27.8%

Total return, distributions reinvested, each window to Nov 18, 2026.

Ten largest positions

HoldingWeight
ADMA Biologics Inc2.61%
Palomar Holdings Inc2.25%
TG Therapeutics Inc2.17%
Inspire Medical Systems Inc2.17%
TransMedics Group Inc2.15%
Sezzle Inc2.14%
QuinStreet Inc1.92%
Millrose Properties Inc1.86%
Paycom Software Inc1.83%
Progyny Inc1.68%

GRPZ top ten by weight, 20.8% of the fund, of its 88 equity positions, from the holdings published by its issuer for Nov 17, 2026.

Facts

Equity fund · Tracks the S&P SmallCap 600 GARP Index · First traded Mar 27, 2024 · Benchmark Its own holdings, as of Nov 17, 2026

Source: ETFIQ, from issuer disclosures, SEC filings and exchange prices. Returns from daily closes, distributions reinvested; each number is dated beside it, and every one is on the fund’s page.Cite as: ETFIQ, GRPZ Fact Sheet: Invesco S&P SmallCap 600 GARP ETF. Data as of Nov 18, 2026. https://etfiq.com/funds/grpz/fact-sheet/ETFIQ is an independent publisher. Not an issuer, broker or adviser. No recommendations. Printed from etfiq.com/funds/grpz.